Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution
2018 ◽
Vol 26
(5)
◽
pp. 1227-1235
◽
2011 ◽
Vol 19
(5)
◽
pp. 431-436
◽
2017 ◽
Vol 14
(2)
◽
pp. e161-e166
◽
2011 ◽
Vol 16
(11)
◽
pp. 1520-1526
◽